HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
Clinical trials for HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for AML patients: targeted pill may keep cancer away after transplant
Disease control Recruiting nowThis study tests whether a daily pill called ivosidenib can help prevent acute myeloid leukemia (AML) from coming back after a stem cell transplant. About 75 adults with a specific IDH1 gene mutation will receive either the drug or a placebo. The goal is to see if the drug extend…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
New inhaled drug aims to shield vulnerable patients from deadly lung infections
Disease control Recruiting nowThis study tests an experimental inhaled drug called PUL-042 in 100 people with blood cancers (like leukemia or lymphoma) or those who have had a stem cell transplant. Participants have a viral lung infection (PIV, hMPV, or RSV). The goal is to see if PUL-042 can prevent the infe…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
Phase: PHASE2 • Sponsor: Pulmotect, Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC